Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMUG | ISIN: FI4000506811 | Ticker-Symbol: 5NX
Frankfurt
27.06.25 | 08:07
11,650 Euro
-3,72 % -0,450
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXSTIM OYJ Chart 1 Jahr
5-Tage-Chart
NEXSTIM OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
12,50012,80028.06.

Aktuelle News zur NEXSTIM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNexstim Oyj: Nexstim Receives NBS System 5 Order from a University Hospital in Germany123Press release, Helsinki, 23 June 2025 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from a University Hospital in Germany Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order...
► Artikel lesen
05.05.Nexstim Oyj: Nexstim Plc Business Update Q1 2025138Press release, Helsinki, 5 May 2025, at 9 AM (EEST) Nexstim Plc Business Update Q1 2025 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the key highlights of the Company's business operations...
► Artikel lesen
27.02.Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2024197Company announcement, Helsinki 27 February 2025 at 9 am (EET) NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2024 NEXSTIM CONTINUED PROFITABLE GROWTH AND SIGNED SIGNIFICANT PARTNERSHIPS July-December 2024 The...
► Artikel lesen
NEXSTIM Aktie jetzt für 0€ handeln
15.01.Nexstim Oyj: Insider Information: Nexstim Plc and Sinaptica Therapeutics, Inc. Announce Initiation of Co-Development of the SinaptiStim Precision Neuromodulation System to treat Alzheimer's Disease108Company Announcement, Helsinki, 15 January 2025 at 9 AM (EET) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") and Sinaptica Therapeutics, Inc. ("Sinaptica"), a clinical-stage company leading the development...
► Artikel lesen
29.11.24Nexstim Oyj: Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement and agreeing on a maximum of EUR 5,095,000 equity investment into Nexstim306Company Announcement, Helsinki, 29 November 2024 at 9:15 AM (EET) Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement...
► Artikel lesen
16.08.24Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2024 (unaudited)162Company announcement, Helsinki, August 16, 2024 at 9 am (EEST) NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2024 (UNAUDITED) NEXSTIM CONTINUED TO GROW AND IMPROVED ITS PROFITABILITY IN THE FIRST...
► Artikel lesen
6 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1